Aspirin May Help Reduce the Risk of Stomach Cancer

Recent research has found that taking aspirin might help lower the risk of developing gastric (stomach) cancer, especially with long-term use. This study looked at data from thousands of people across different countries to understand the impact of aspirin and statins on stomach cancer.

Key Findings

• Aspirin and Stomach Cancer: The study showed that people who regularly took aspirin had a 28% lower risk of developing stomach cancer compared to those who didn’t use aspirin. The longer someone used aspirin, the more significant the protective effect. For example, those who took aspirin for 15 years or more had a 59% lower risk.
• Statins and Stomach Cancer: Unlike aspirin, statins did not show a significant impact on reducing the risk of stomach cancer in this study.

How Aspirin Works Aspirin is well-known for its ability to reduce inflammation and lower the risk of heart disease. In terms of cancer prevention, aspirin helps by inhibiting certain pathways that are involved in cancer development. Specifically, it blocks an enzyme that can contribute to tumor growth.

What This Means for You If you have a history of stomach issues or are at high risk for stomach cancer, you might want to talk to your doctor about whether aspirin could be beneficial for you. It’s important to note that while aspirin can have protective effects, it also carries risks, such as gastrointestinal bleeding, so it should not be taken without medical advice.

Conclusion This study adds to the growing evidence that long-term aspirin use could play a role in reducing the risk of stomach cancer. However, it’s crucial to consult with a healthcare provider to weigh the benefits and risks before starting aspirin therapy.

Reference For more details, you can access the full study at https://doi.org/10.1002/cncr.35510.